Hepatic clearance of arterially infused ferromagnetic particles

International Journal of Hyperthermia

Volumn 19, Issue 1, 2003, Pages 23-34

  Moroz, Paul ^a   Jones, S K ^b   Metcalf, C ^c   Gray, B N ^b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b Sirtex Medical Ltd   (Australia)

^c ROYAL PERTH HOSPITAL   (Australia)

Author keywords

Arterial emobolization hyperthermia; Clearance; Ferromagnetic; Hysteresis; Microsphere

Indexed keywords

FERRIC OXIDE; FERROMAGNETIC MATERIAL; IODINATED POPPYSEED OIL; IRON; POLYMER; WATER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ARTIFICIAL EMBOLISM; BIOCHEMISTRY; BLOOD ANALYSIS; BLOOD SAMPLING; BLOOD VESSEL OCCLUSION; CHEMICAL ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; DRUG SAFETY; DRUG TOLERABILITY; HEMATOLOGICAL PARAMETERS; HEPATIC ARTERY; HISTOPATHOLOGY; HYPERTHERMIC THERAPY; HYSTERESIS; IMMUNOGENICITY; INFUSION; LIVER CLEARANCE; LIVER NECROSIS; LUNG; NONHUMAN; PHAGOCYTOSIS; SAMPLE; STATISTICAL SIGNIFICANCE; SURVIVAL; SUSPENSION; SWINE; TISSUE; TISSUE LEVEL; VISCERA;

ANIMALS; EMBOLIZATION, THERAPEUTIC; FERRIC COMPOUNDS; HYPERTHERMIA, INDUCED; IODIZED OIL; LIVER; LIVER NEOPLASMS; LUNG; MICROSPHERES; PHAGOCYTOSIS; SWINE;

EID: 0037224681     PISSN: 02656736     EISSN: None     Source Type: Journal    
DOI: 10.1080/02656730210147303     Document Type: Article

References (23)

1. Mitsumori M, Hiraoka M, Shibata T, Okuno Y, Nishimura Y, Abe M, Hasegawa M, Nagae H, Ebisawa Y. Targeted hyperthermia using dextran magnetite complex: A new treatment modality for liver tumours. Hepato-Gastroenterology 1996; 43: 1431-7.
2. Minamimura T, Sato H, Kasaoka S, Saito T, Ishizawa S, Takemori S, Tazawa K, Tsukada K. Tumour regression by inductive hyperthermia combined with hepatic embolization using dextran magnetite incorporated microspheres in rats. Int J Oncol 2000; 16: 1153-8.
3. Moroz P, Jones SK, Winter J, Gray BN. Targeting liver tumours with hyperthermia: Ferromagnetic embolization in a rabbit liver tumour model. J Surg Oncol 2001; 78: 22-9.
4. Jones S, Winter J, Gray BN. Treatment of experimental rabbit liver tumours by selectively targeted hyperthermia. Int J Hyperthermia 2002; 18: 117-128.
5. Moroz P, Jones SK, Gray BN. The effect of tumour size on ferromagnetic embolization hyperthermia. Int J Hyperthermia 2002; 18: 129-140.
6. Stribley KV, Gray BN, Chimel R, Heggie JCP, Bennett RC. Internal radiotherapy for hepatic metastases; The blood supply of hepatic metastases. J Surg Res 1982; 33: 25-32.
7. Archer S, Gray BN. The vascularization of small liver metastases. Br J Surg 1989; 76: 545-8.
8. Archer S, Gray BN. Comparison of portal vein chemotherapy with hepatic arterial chemotherapy in the treatment of liver micrometastases. Am J Surg 1990; 159: 325-9.
9. Breedis C, Young G. The blood supply of neoplasms in the liver. Am J Pathol 1954; 30: 969-77.
10. Burton MA, Gray BN, Klemp PF, Kelleher DK, Hardy N. Selective internal radiation therapy: Distribution of radiation in the liver. Eur J Cancer Clin Oncol 1989; 25: 1487-91.
11. m macroaggregated albumin. Br J Radiol 1997; 70: 823-8.
12. Kemeny N, Huang Y, Cohen AM, Shi W, Conti JA, Brennan MF, Bertino JR, Turnbull AD, Sullivan D, Stockman J, Blumgart LH, Fong Y. 1999 Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. New England J Med 1999; 341: 2039-48.
13. Campbell AM, Bailey IH, Burton MA. Analysis of the distribution of intra-arterial microspheres in human liver following hepatic yttrium-90 microsphere therapy. Phys Med Biol 2000; 45: 1023-33.
14. Moroz P, Jones SK, Metcalf C, Gray BN. Histologic analysis of liver tissue following hepatic arterial infusion of ferromagnetic particles in a rabbit liver tumour model. Biometals 2001, in press.
15. Frandson RD. Anatomy and Physiology of Farm Animals, 2nd edn. Philadelphia: Lea & Febiger, 1974.
16. Willard HH, Merritt LL, Dean JA, Settle FA, eds. Instrumental Methods of Analysis, 7th edn. California: Wadsworth Publishing Co, 1988.
17. Moroz P, Anderson JEM, Van Hazel G, Gray BN. Effect of selective internal radiation therapy and hepatic arterial chemotherapy on normal liver volume and spleen volume. J Surg Oncol 2001; 78: 248-52.
18. Gordon RT, Hines JR, Gordon D. Intracellular hyperthermia: A biophysical approach to cancer treatment via intracellular temperature and biophysical alterations. Med Hypo 1979; 5: 83-102.
19. Sako M, Yokogawa S, Sakomoto K, Adachi S, Hirota S, Okada S, Murao S. Transcatheter microembolization with ferropolysaccharide. A new approach to ferromagnetic embolization of tumours: A preliminary report. Invest Radiol 1982; 17: 573-82.
20. Iwai K, Maeda H, Konno T, Matsumura Y, Yamashita R, Yamasaki K, Hirayama S, Miyauchi Y. Tumour targeting by arterial administration of lipids: Rabbit model with VX2 carcinoma in the liver. Anticancer Res 1987; 7: 321-8.
21. Gelman S, Fowler KC, Smith LR. Liver circulation and function during isoflurane and halothane anesthesia. Anesthesiology 1984; 61: 726-30.
22. Crawford MW, Lerman J, Saldivia V, Carmichael FJ. Hemodynamic and organ blood flow responses to halothane and sevoflurane anesthesia during spontaneous ventilation. Anesth Analg 1992; 75: 1000-6.
23. Trevor AJ, Miller RD. General anesthetics. In: Katzung BG, ed. Basic and Clinical Pharmacology, 5th edn. USA: Appleton and Lange, 1992; 350-62.